Full Name
Cindy L. Bell
Job title
Executive VP, Corporate Development
Affiliation
Genome Canada
Speaker bio
Cindy Bell is Genome Canada’s Executive Vice-President, Corporate Development. She provides leadership in the development and implementation of strategic initiatives and approaches to enhance Genome Canada’s business model and secure funding to support genomics research in Canada.
Dr. Bell joined Genome Canada in August 2000. From 2000-2008 she held the position of Vice-President, Genomics Programs, in which she was responsible for providing policy and strategic advice on scientific and other aspects of Genome Canada’s programs. This included overseeing and managing the peer review process used to establish the research program of Genome Canada.
Prior to joining Genome Canada, Dr. Bell was a Deputy Director in Programs Branch at the Canadian Institutes of Health Research (CIHR) from 1994 to 2000. At CIHR she managed a number of research programs and was involved in policy development and implementation.
From 1986 to 1994, Dr. Bell was a researcher at the University of California, Riverside. Her research focused on investigating the basic defect in the genetic disease, Cystic Fibrosis. She obtained her PhD in Genetics from McGill University in 1986.
Dr. Bell joined Genome Canada in August 2000. From 2000-2008 she held the position of Vice-President, Genomics Programs, in which she was responsible for providing policy and strategic advice on scientific and other aspects of Genome Canada’s programs. This included overseeing and managing the peer review process used to establish the research program of Genome Canada.
Prior to joining Genome Canada, Dr. Bell was a Deputy Director in Programs Branch at the Canadian Institutes of Health Research (CIHR) from 1994 to 2000. At CIHR she managed a number of research programs and was involved in policy development and implementation.
From 1986 to 1994, Dr. Bell was a researcher at the University of California, Riverside. Her research focused on investigating the basic defect in the genetic disease, Cystic Fibrosis. She obtained her PhD in Genetics from McGill University in 1986.
Speaking At
